KaloBios submits request to appeal Nasdaq delisting

December 29, 2015 6:06 PM

23 0

KaloBios submits request to appeal Nasdaq delisting

KaloBios Pharmaceuticals Inc, which fired its controversial Chief Executive Martin Shkreli earlier this month, said it had requested an appeal of Nasdaq's decision to delist its shares.

The embattled drugmaker said last week it had been notified by Nasdaq that its stock would be delisted using the exchange operator's "discretionary" authority.

Also read: BAT Wins Reynolds With Sweetened $49.4 Billion Buyout Bid

Read more

To category page

Loading...